Ramon Andrade de Mello
AuthID: R-00F-MXH
11
TITLE: How complement activation via a C3a receptor pathway alters CD4+T lymphocytes and mediates lung cancer progression? -future perspectives
AUTHORS: Marcos Magalhaes Filho; Pedro Nazareth Aguiar Junior; Jacob J Adashek; Ramon Andrade De Mello;
PUBLISHED: 2019, SOURCE: JOURNAL OF THORACIC DISEASE, VOLUME: 11
AUTHORS: Marcos Magalhaes Filho; Pedro Nazareth Aguiar Junior; Jacob J Adashek; Ramon Andrade De Mello;
PUBLISHED: 2019, SOURCE: JOURNAL OF THORACIC DISEASE, VOLUME: 11
INDEXED IN: 
Scopus 
WOS
Scopus WOS12
TITLE: Hot topics in epigenetic regulation of cancer self-renewal for pancreatic tumors: future trends
AUTHORS: Ramon Andrade De Mello; Ines Faleiro; Joana D Apolonio; Uri Tabori; Aryeh J Price; Vania P Roberto; Pedro Castelo Branco;
PUBLISHED: 2019, SOURCE: FUTURE ONCOLOGY, VOLUME: 15, ISSUE: 7
AUTHORS: Ramon Andrade De Mello; Ines Faleiro; Joana D Apolonio; Uri Tabori; Aryeh J Price; Vania P Roberto; Pedro Castelo Branco;
PUBLISHED: 2019, SOURCE: FUTURE ONCOLOGY, VOLUME: 15, ISSUE: 7
INDEXED IN: WOS
WOS13
TITLE: Chronic obstructive pulmonary disease alters immune cell composition and immune checkpoint inhibitor efficacy in non-small cell lung cancer
AUTHORS: Magalhaes, M; Aguiar, PN; de Mello, RA;
PUBLISHED: 2019, SOURCE: ANNALS OF TRANSLATIONAL MEDICINE, VOLUME: 7
AUTHORS: Magalhaes, M; Aguiar, PN; de Mello, RA;
PUBLISHED: 2019, SOURCE: ANNALS OF TRANSLATIONAL MEDICINE, VOLUME: 7
INDEXED IN: Scopus WOS
Scopus WOS14
TITLE: PALOMA-3 clinical trial: is there a significant benefit in overall survival for breast cancer? Is it worth it?
AUTHORS: Jacob J Adashek; Pedro N Aguiar; Pedro Castelo Branco; Gilberto L Lopes; Ramon Andrade de Mello;
PUBLISHED: 2019, SOURCE: FUTURE ONCOLOGY, VOLUME: 15, ISSUE: 13
AUTHORS: Jacob J Adashek; Pedro N Aguiar; Pedro Castelo Branco; Gilberto L Lopes; Ramon Andrade de Mello;
PUBLISHED: 2019, SOURCE: FUTURE ONCOLOGY, VOLUME: 15, ISSUE: 13
INDEXED IN: Scopus WOS
Scopus WOS15
TITLE: Comparative outcome assessment of epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of advanced non-small-cell lung cancer: A network meta-analysis
AUTHORS: De Mello, RA; Escriu, C; Castelo Branco, P; Cabral, PL; Mountzios, G; Lopes, GL; Madureira, P;
PUBLISHED: 2018, SOURCE: Oncotarget, VOLUME: 9, ISSUE: 14
AUTHORS: De Mello, RA; Escriu, C; Castelo Branco, P; Cabral, PL; Mountzios, G; Lopes, GL; Madureira, P;
PUBLISHED: 2018, SOURCE: Oncotarget, VOLUME: 9, ISSUE: 14
INDEXED IN: Scopus
Scopus16
TITLE: Lung cancer: a brief review of epidemiology and screening
AUTHORS: Claudia Gouvinhas; Ramon Andrade De Mello; Daniela Oliveira; Jose Manuel Castro Lopes ; Pedro Castelo Branco; Ricardo Sales dos Santos; Venceslau Hespanhol ; Daniel Humberto Pozza ;
PUBLISHED: 2018, SOURCE: FUTURE ONCOLOGY, VOLUME: 14, ISSUE: 6
AUTHORS: Claudia Gouvinhas; Ramon Andrade De Mello; Daniela Oliveira; Jose Manuel Castro Lopes ; Pedro Castelo Branco; Ricardo Sales dos Santos; Venceslau Hespanhol ; Daniel Humberto Pozza ;
PUBLISHED: 2018, SOURCE: FUTURE ONCOLOGY, VOLUME: 14, ISSUE: 6
17
TITLE: Cost-effectiveness and budget impact of lung cancer immunotherapy in South America: strategies to improve access
AUTHORS: Pedro Aguiar Jr; Auro Del Giglio; Luke Alastair Perry; Jahan Penny Dimri; Hani Babiker; Hakaru Tadokoro; Gilberto Lopes; Ramon Andrade De Mello;
PUBLISHED: 2018, SOURCE: IMMUNOTHERAPY, VOLUME: 10, ISSUE: 10
AUTHORS: Pedro Aguiar Jr; Auro Del Giglio; Luke Alastair Perry; Jahan Penny Dimri; Hani Babiker; Hakaru Tadokoro; Gilberto Lopes; Ramon Andrade De Mello;
PUBLISHED: 2018, SOURCE: IMMUNOTHERAPY, VOLUME: 10, ISSUE: 10
INDEXED IN: WOS
WOS18
TITLE: MetaLanc9 as a novel biomarker for non-small cell lung cancer: promising treatments via a PGK1-activated AKT/mTOR pathway
AUTHORS: Ramon Andrade De Mello; Pedro Nazareth Aguiar; Hakaru Tadokoro; Tallita Meciany Farias Vieira; Pedro Castelo Branco; Gilberto de Lima Lopes; Daniel Humberto Pozza ;
PUBLISHED: 2018, SOURCE: JOURNAL OF THORACIC DISEASE, VOLUME: 10, ISSUE: S16
AUTHORS: Ramon Andrade De Mello; Pedro Nazareth Aguiar; Hakaru Tadokoro; Tallita Meciany Farias Vieira; Pedro Castelo Branco; Gilberto de Lima Lopes; Daniel Humberto Pozza ;
PUBLISHED: 2018, SOURCE: JOURNAL OF THORACIC DISEASE, VOLUME: 10, ISSUE: S16
19
TITLE: What Will We Expect From Novel Therapies to Esophageal and Gastric Malignancies?
AUTHORS: Ramon Andrade De Mello; Luis Castelo-Branco; Pedro Castelo-Branco; Daniel Humberto Pozza ; Louis Vermeulen; Sofia Palacio; Matthew Salzberg; Craig C Lockhart;
PUBLISHED: 2018, SOURCE: American Society of Clinical Oncology Educational Book, ISSUE: 38
AUTHORS: Ramon Andrade De Mello; Luis Castelo-Branco; Pedro Castelo-Branco; Daniel Humberto Pozza ; Louis Vermeulen; Sofia Palacio; Matthew Salzberg; Craig C Lockhart;
PUBLISHED: 2018, SOURCE: American Society of Clinical Oncology Educational Book, ISSUE: 38
20
TITLE: Potential role of immunotherapy in advanced non-small-cell lung cancer
AUTHORS: Ramon Andrade de Mello; Ana Flavia Veloso; Paulo Esrom Catarina; Sara Nadine; Georgios Antoniou;
PUBLISHED: 2017, SOURCE: ONCOTARGETS AND THERAPY, VOLUME: 10
AUTHORS: Ramon Andrade de Mello; Ana Flavia Veloso; Paulo Esrom Catarina; Sara Nadine; Georgios Antoniou;
PUBLISHED: 2017, SOURCE: ONCOTARGETS AND THERAPY, VOLUME: 10
INDEXED IN: WOS
WOS